福元医药 - Financials

福元医药 — Financial Statements

Annual Quarterly

5 10 All

Income Statement

Balance Sheet

Cash Flow

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018
+Revenue	3.4B	3.3B	3.2B	2.8B	2.5B	2.4B	2.0B
Revenue Growth %	3.2%	3.1%	14.2%	12.0%	4.5%	20.0%	--
Total Revenue	3.4B	3.3B	3.2B	2.8B	2.5B	2.4B	2.0B
Cost Of Revenue	1.1B	1.1B	1.0B	865.0M	733.0M	593.0M	522.0M
+Gross Profit	2.3B	2.2B	2.2B	2.0B	1.8B	1.8B	1.5B
Gross Margin %	67.1%	66.6%	68.2%	69.5%	71.1%	75.5%	74.2%
Total Operating Cost	3.0B	2.8B	2.8B	2.5B	2.2B	2.2B	1.8B
Selling Expenses	1.3B	1.2B	1.4B	1.3B	1.2B	1.3B	1.0B
Admin Expenses	136.0M	138.0M	132.0M	126.0M	96.9M	91.5M	81.0M
Rd Expenses	417.0M	353.0M	240.0M	180.0M	141.0M	172.0M	142.0M
Finance Expenses	-35.2M	-50.7M	-28.4M	4.0M	8.4M	13.3M	19.4M
+Operating Income	543.0M	552.0M	477.0M	360.0M	309.0M	245.0M	236.0M
Operating Margin %	15.8%	16.5%	14.7%	12.7%	12.2%	10.1%	11.7%
Non Operating Income	2.5M	2.8M	10.9M	7.4M	2.2M	2.3M	912,900
Non Operating Expenses	5.0M	5.7M	1.6M	2.2M	11.6M	516,200	1.4M
Investment Income	10.8M	1.8M	2.8M	2.1M	2.4M	1.6M	2.6M
Asset Disposal Income	1.0M	225,900	136,800	10,700	-652,000	-84,900	-192,200
Asset Impairment Loss	10.7M	13.7M	10.5M	9.5M	4.9M	3.0M	7.5M
Other Income	39.2M	26.9M	14.9M	7.2M	21.3M	16.3M	20.2M
Income Before Tax	540.0M	549.0M	486.0M	366.0M	300.0M	247.0M	236.0M
Income Tax	48.0M	56.8M	46.3M	49.8M	35.3M	26.5M	28.9M
+Net Income	492.0M	492.0M	440.0M	316.0M	265.0M	220.0M	207.0M
Net Margin %	14.3%	14.7%	13.6%	11.1%	10.5%	9.1%	10.2%
Net Income Attributable	489.0M	489.0M	439.0M	314.0M	263.0M	219.0M	200.0M
Minority Interest	3.4M	3.6M	719,300	1.4M	1.8M	1.6M	6.3M
Eps Basic	1.04	1.02	1.04	0.87	0.73	0.61	0.58
Eps Diluted	1.04	1.02	1.04	0.87	0.73	0.61	0.58

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018
Cash And Equivalents	794.0M	2.5B	2.5B	435.0M	270.0M	463.0M	157.0M
Trading Financial Assets	1.6B	--	--	100.0M	50.0M	--	--
Accounts Receivable	355.0M	346.0M	396.0M	338.0M	375.0M	413.0M	415.0M
Notes Receivable	--	--	--	--	--	--	51.8M
Notes And Accounts Receivable	355.0M	346.0M	396.0M	338.0M	375.0M	413.0M	466.0M
Prepayments	24.5M	41.7M	17.5M	21.2M	17.9M	6.6M	8.0M
Inventory	348.0M	307.0M	339.0M	324.0M	277.0M	266.0M	196.0M
Total Current Assets	3.2B	3.3B	3.4B	1.3B	1.1B	1.2B	971.0M
Fixed Assets	--	679.0M	675.0M	568.0M	389.0M	398.0M	--
Fixed Assets Total	673.0M	679.0M	675.0M	568.0M	389.0M	398.0M	397.0M
Construction In Progress	--	256.0M	46.7M	100.0M	176.0M	35.4M	--
Construction In Progress Total	719.0M	256.0M	46.7M	100.0M	176.0M	35.4M	9.3M
Intangible Assets	139.0M	150.0M	143.0M	144.0M	53.8M	57.9M	60.9M
Long Term Deferred Expenses	21.8M	22.9M	17.6M	328,800	690,000	4.5M	10.9M
Total Non Current Assets	1.6B	1.2B	950.0M	874.0M	629.0M	515.0M	489.0M
Total Assets	4.8B	4.5B	4.3B	2.2B	1.7B	1.7B	1.5B
Short Term Borrowings	40.0M	55.1M	40.0M	70.1M	48.3M	243.0M	147.0M
Accounts Payable	287.0M	132.0M	144.0M	130.0M	92.9M	85.1M	71.3M
Advance Receipts	82,800	78,900	3,000	--	--	40.7M	23.3M
Contract Liabilities	36.6M	39.7M	81.0M	42.8M	34.3M	--	--
Total Current Liabilities	1.2B	998.0M	1.1B	866.0M	685.0M	829.0M	698.0M
Long Term Borrowings	--	12.4M	17.3M	7.3M	--	35.6M	67.5M
Total Non Current Liabilities	70.6M	72.9M	90.0M	71.4M	10.4M	43.9M	76.6M
Total Liabilities	1.3B	1.1B	1.1B	938.0M	695.0M	872.0M	775.0M
Paid In Capital	480.0M	480.0M	480.0M	360.0M	360.0M	360.0M	64.1M
Capital Reserve	1.7B	1.7B	1.7B	146.0M	146.0M	146.0M	153.0M
Surplus Reserve	192.0M	154.0M	115.0M	78.4M	53.4M	35.8M	43.8M
Retained Earnings	1.4B	1.2B	902.0M	608.0M	426.0M	289.0M	412.0M
Minority Equity	11.5M	8.1M	4.6M	3.8M	2.4M	607,000	-994,100
Equity Attributable	3.5B	3.5B	3.2B	1.2B	1.0B	848.0M	686.0M
Total Equity	3.6B	3.5B	3.2B	1.2B	1.0B	848.0M	685.0M

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018
Cash From Sales	3.3B	3.2B	3.1B	2.8B	2.5B	2.5B	1.9B
Tax Refunds Received	2.2M	3.6M	3.0M	7.1M	6.3M	2.5M	1.4M
Total Operating Cash Inflow	3.5B	3.3B	3.2B	2.9B	2.6B	2.5B	2.0B
Cash Paid For Goods	554.0M	533.0M	500.0M	451.0M	406.0M	284.0M	235.0M
Cash Paid To Employees	635.0M	586.0M	536.0M	463.0M	398.0M	394.0M	332.0M
Taxes Paid	314.0M	381.0M	314.0M	287.0M	236.0M	243.0M	276.0M
Total Operating Cash Outflow	2.8B	2.8B	2.6B	2.3B	2.2B	2.2B	1.8B
Operating Cash Flow	691.0M	556.0M	660.0M	528.0M	387.0M	301.0M	238.0M
Total Investing Cash Inflow	2.4B	392.0M	474.0M	718.0M	240.0M	265.0M	360.0M
Total Investing Cash Outflow	4.4B	777.0M	505.0M	958.0M	473.0M	226.0M	505.0M
Investing Cash Flow	-2.0B	-386.0M	-31.4M	-240.0M	-233.0M	39.0M	-145.0M
Cash From Borrowings	49.9M	55.0M	50.4M	214.0M	146.0M	243.0M	212.0M
Dividends And Interest Paid	237.0M	195.0M	111.0M	114.0M	119.0M	70.0M	13.9M
Debt Repayments	82.2M	44.9M	72.5M	214.0M	373.0M	171.0M	282.0M
Total Financing Cash Inflow	49.9M	55.0M	1.7B	214.0M	146.0M	243.0M	237.0M
Total Financing Cash Outflow	517.0M	262.0M	242.0M	354.0M	493.0M	277.0M	365.0M
Financing Cash Flow	-467.0M	-207.0M	1.5B	-139.0M	-346.0M	-34.2M	-128.0M
Net Change In Cash	-1.8B	-36.4M	2.1B	148.0M	-193.0M	306.0M	-34.5M
Ending Cash Balance	714.0M	2.5B	2.5B	418.0M	270.0M	463.0M	156.0M
Capex	392.0M	366.0M	135.0M	193.0M	169.0M	86.4M	56.8M